New treatment for Advanced melanoma

Ipilimumab is a new drug treatment, monotherapy that is being investigated in patients with Advanced melanoma.In a report from the Lancet a  phase 2 clinical trial  showed that the drug produced a dose dependant effect.Trials are still on going but the reaserch around this cancer is promising.

Coffee and tea equals no diabetes?

According to medical news online, coffee,tea have been linked to reduce risk of developing  type 2 diabetes.This follows a recent study in half a million participants.Further details of the study can be found  on
Medical News website or you can follow it by clicking the story item on the left......

Have a great day, now let me put the kettle ON....

The Gift of Health

Newsweeks gives a run down of the top 10 health related gifts.Read it by clicking title and give the gift of health this Christmas.....HO HO HO..

A rough guide to herbal medicine

You maybe new to herbal medicine,or just intereseted in knowing what works for what.This video is a guide to help you learn about what herbal medince is out their and if its worth your time buying it.ENJOY.....

Foods to AVOID when losing weight

Brenda chats about some foods to avoid.Its not what you think

Super bugs!!!!

Source:http://www.abc.net.au/quantum/scripts99/9904/img/bacteria.jpg

SUPER-BUGS....With bacteria developing an ever growing resistance is it possible that we will go back to the 1800s where everyone died of a simple infection....click title for story

Best diets 2010

topdietreview.com has the top diets of 2010. The live rankings are done by real people using the dieting systems to lose weight.


The top ten weight loss diets are as follows:

1) Nutrisystem

2) Medifast Diet

3) Bistro MD Gourmet Diet

4) Jillian Michaels

5) The South Beach Diet

6) Joy Bauer's LIFE Diet

7) The Sonoma Diet

8) eDiets

9) The Duke Diet

10) The Zone Diet


see topdietreview.com for the full exhaustive list

Approval for pain drug

FDA is about to approve Exalgo (hydromorphone HCl), for pain pending investigations about the drugs addictive properties......


Go to
http://www.fiercebiotech.com/story/fda-extends-review-pain-drug/2009-11-20

Top 10 biotech drugs of 2008

Fierce biotechshow cases the 10 most influencial drugs that have changed medicine as we know it...

SWINE FLU MYTHS THAT COULD KILL YOU

Most people have made up myths regarding swine flu.Most peoples ideas are based on others unfounded ideas or even worse the media.For instance some people think that swine flu can be stopped with a mask....N95.The new scientists discusses 8myths surrounding swine flu....YOU DECIDE

New Diabetes Drug..... best yet??

The pharmaceutical company Roche is said to be working on a new drug taspoglutide for diabetic patients.The antidiabetic drug has shown to be better in lowering blood glucose levels than the current blockbuster treatment byetta.This announcement comes as a results of good clinical study results where taspoglutide was shown to lower blood sugar levels

Reference

Wall street journal

Ribavirin to Treat Influenza

The New england medical journal reports the use of ribavirin in the treatment of influenza including the H1N1 (Swine flu) virusis.Ribavirin is antiviral drug with a mode of action that targets both DNA and RNA viruses.It is currently approved in the United States for the treatment of hepatitis C and respiratory syncytial virus.In the advent of another pandemic we could see this drug being used or approved for flu treatment.

Reference
http://content.nejm.org/cgi/content/full/361/17/1713

FDA approves new drug for Chronic Lymphocytic Leukemia

The FDA has recently approved the drug Arzerra (ofatumumab) for patients with chronic lymphocytic leukemia (CLL).This is good news since nearly 16,000 cases of CLL are diagnosed each year.See reference for full story on the drug.


Reference

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187966.htm

New drug for treatment of osteoporosis

The drug compound MK5442 is currently undergoing phase 2 clinical trials for the treatment of osteoporosis.The study focuses on treatment of osteoporosis in postmenopasual women aged 45-80, who have been previously treated with an oral bisphosphate.MK5442 has been shown to increase bone density and as a result reduce the progression osteoporosis.The study is being conducted by Merck and will end i
n 2011.For those interested in participating in trial or getting information on the
trial check reference below.

References

http://clinicaltrials.gov/ct2/show/NCT00996801?rcv_d=14&rank=8

Magic pill for weight loss

The lancet has an article show casing the drug liraglutide.Clinical trial phase 2 studies funded by novo nordisk, have shown that the drug could lead to a reduction in weight loss in obese people.The drug has also been shown to reduce weight in non-insulin dependent type 2 diabetes patients.

Article preview

Background
The frequency of obesity has risen dramatically in recent years but only few safe and effective drugs are currently available. We assessed the effect of liraglutide on bodyweight and tolerability in obese individuals without type 2 diabetes.
Methods
We did a double-blind, placebo-controlled 20-week trial, with open-label orlistat comparator in 19 sites in Europe. 564 individuals (18—65 years of age, body-mass index 30—40 kg/m2) were randomly assigned, with a telephone or web-based system, to one of four liraglutide doses (1·2 mg, 1·8 mg, 2·4 mg, or 3·0 mg, n=90—95) or to placebo (n=98) administered once a day subcutaneously, or orlistat (120 mg, n=95) three times a day orally. All individuals had a 500 kcal per day energy-deficit diet and increased their physical activity throughout the trial, including the 2-week run-in. Weight change analysed by intention to treat was the primary endpoint. An 84-week open-label extension followed. This study is registered with ClinicalTrials.gov, number NCT00422058.
Findings
Participants on liraglutide lost significantly more weight than did those on placebo (p=0·003 for liraglutide 1·2 mg and p<0·0001 for liraglutide 1·8—3·0 mg) and orlistat (p=0·003 for liraglutide 2·4 mg and p<0·0001 for liraglutide 3·0 mg). Mean weight loss with liraglutide 1·2—3·0 mg was 4·8 kg, 5·5 kg, 6·3 kg, and 7·2 kg compared with 2·8 kg with placebo and 4·1 kg with orlistat, and was 2·1 kg (95% CI 0·6—3·6) to 4·4 kg (2·9—6·0) greater than that with placebo. More individuals (76%, n=70) lost more than 5% weight with liraglutide 3·0 mg that with placebo (30%, n=29) or orlistat (44%, n=42). Liraglutide reduced blood pressure at all doses, and reduced the prevalence of prediabetes (84—96% reduction) with 1·8—3·0 mg per day. Nausea and vomiting occurred more often in individuals on liraglutide than in those on placebo, but adverse events were mainly transient and rarely led to discontinuation of treatment.
Interpretation
Liraglutide treatment over 20 weeks is well tolerated, induces weight loss, improves certain obesity-related risk factors, and reduces prediabetes.
Funding
Novo Nordisk A/S, Bagsvaerd, Denmark.

References
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61375-1/fulltext

Votrient approved for advanced kidney cancer

After showing positive clinical data, the FDA has recently approved the drug votrient (pazopanib hydrochloride) for the treatment of advanced kidney cancer.The drug is said to work by restricting proliferation of blood vessels to a developing tumor and as a result starves the tumor of the nutrients or factors it needs to grow.In the USA alone they are approximately 50,000 people who suffer from kidney cancer so its good to see a drug come through the pipeline to market

References
http://health.usnews.com/articles/health/healthday/2009/10/20/votrient-approved-for-advanced-kidney-cancer.html

Novel breast cancer drug

GSK is currently conducting phase2 clinical trials for compound LY573636.The compound has shown promising results in advanced or resistant cancers.LY573636 has also been effective against a multitude of malignancies...see abstract for details of drug also check references for details on clinical trials being conducted in regards to this drug.

Article preview

Novel acyl sulfonamide LY573636-sodium: Effect on hematopoietic malignant cells

Authors: Talin Haritunians, Saskia Gueller, James O'Kelly, Robert Ilaria, H. Phillip Koeffler

Affiliations: Division of Hematology/Oncology, Cedars-Sinai Medical Center and UCLA School of Medicine, Los Angeles, CA 90048, USA

Pages: 1237-1242

Abstract:

LY573636-sodium is a promising anti-tumor agent, which causes growth arrest and apoptosis of a variety of human solid tumors in vitro and in vivo. Moreover, studies have shown that the compound is selectively toxic towards tumor cells over their normal counterparts. This targeted effect makes LY573636 a candidate for combined therapy regimens in patients with advanced or resistant cancers. We studied for the first time, the anti-tumor properties of LY573636 against a variety of human hematopoietic malignancies, including AML, B-ALL, large B-cell and mantle cell lymphoma cell lines. Cells were treated with the compound in vitro and its effect on cell proliferation, apoptosis and differentiation was determined. The cell lines underwent growth arrest in response to treatment with LY573636 in a dose-dependent manner. This antiproliferative activity was associated with the induction of apoptosis, loss of mitochondrial membrane potential and induction of reactive oxygen species. Furthermore, we showed that LY573636 was able to induce granulocytic/monocytic differentiation of HL60 and U937 cells. LY573636, as shown before in solid tumors, is effective in hematopoietic cell lines as well. These data suggest the use of LY573636 alone or in combination with conventional chemotherapeutic regimens in hematopoietic malignancies.

References

http://www.spandidos-publications.com/or/article.jsp?article_id=or_20_5_1237
Clinicaltrials.gov

New cervical cancer vaccine approved

According to fierce biotech.com, glaxosmithsklins's (GSK) cervical cancer vaccine cervarix has been approved for market in the USA.The vaccine is said to be the most effective in preventing cervical cancer due to HPV.This is good news for young women, who can now be protected from cervical cancer......


Reference

http://www.fiercebiotech.com/story/glaxo-finally-wins-fda-approval-cervarix/2009-10-19

Zenvia the new hope for MS patients

Fierce biotech.com reports that the drug Zenvia developed by avanir pharmaceuticals, has recently shown successful phase 3 clinical trial results in its ability to relieve Pseudobulbar affect (PBA-(also known as involuntary emotional expression disorder (IEED) and emotional lability) in a subset of multiple sclerosis form of MS.

Reference

http://www.avanir.com/product/product.php?ID=11
http://www.fiercebiotech.com/story/avanir-stock-boosted-zenvia-data/2009-10-09

Saphris for schizophrenia and bipolar

The drug saphris was recently approved(August 09) for the treatment of schizophrenia and type 1 bipolar disorder in adults.The drug will available in us pharmacies soon and will come in 5mg and 10mg strength for sub lingual use.More information can be found on company website.

Reference
http://www.saphris.com/saphris/index.jsp

Three products that will slim you instantly

Consultancy trendbird mentions three diet plans Splenda Mist, Fat Burning Lemonade, and Sensa.Some people would have heard of some of them.The first and most common is splenda,updated version splenda mist is a no calorie sweetner for those who have a sweet tooth but do not want to deal with the added calories that comes with sweets and the like.The next dietry cure is the fat burning lemonade "master cleanser".Its a lemon based product that coverts fats into energy (instantly).Lastly they is sensa which is a dietry supressant suppossedly developed by docters.

These are some of the diet aids released in the past five years hope you find them helpful and as always consult professtionals before embarking on any diets.

References
Sensa Website
splenda mist
http://www.trendbird.co.kr/1595

Coming soon:Afresa for treatment of type 1 and 2 diabetes

The drug-product Afresa developed by mannkind corporation has recently been approved by the FDA for use in type 1 and 2 diabetes in the treatment of hyperglycemia.The drug is insulin therapy that is delivered through an inhalation device called Afresa.It is described on the company website as being an ultra rapid acting mealtime insulin therapy.The advantage of this device will be its ability to be synchronized easily around meals which would make it much easier for diabetes sufferers.....

For details visit company websites,they is no indication when the drug will be in the market place but granted it was approved in may 2009 it should be on pharmacy shelves soon......take care all

Reference
http://www.mannkindcorp.com/afresa-background.aspx

New face masks to protect against flu

The new england medical journal showcases a new face mask with the capability of filtering really small particles.The facemask, called N95 repirator has apparently been shown to be effective at preventing the spread of viruses due to their high filteration capacity.This is good news,since this is a non-pharmaceutical intervention workers (especially healthcare workers can protect themselves)\

Reference
http://content.nejm.org/cgi/content/full/NEJMp0908437

Parkinson's disease: New hope

In a resent study by researchers from the university college London.Scientists where able to generate small electrical currents in 14 healthy volunteers using scalp electrodes.The current produced by these electrodes is said to act upon beta waves in the brain leading to more controlled muscular movement (slower movement).The study adds to a growing number of treatments for Parkinson's.This treatment focuses on using electrical therapy to help regress the symptoms of the disease.A treatment like this is still in its early stages and would take a while it becomes commercially available.As always with Parkinson's its not just the treatment you have to consider, diet and exercise come into play as well....Take care all

Journal preview

Boosting Cortical Activity at Beta-Band Frequencies Slows Movement in Humans Alek Pogosyan1, Louise Doyle Gaynor1, Alexandre Eusebio1 and Peter Brown,

Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, London WC1N 3BG, UK

Summary

Neurons have a striking tendency to engage in oscillatory activities. One important type of oscillatory activity prevalent in the motor system occurs in the beta frequency band, at about 20 Hz. It is manifest during the maintenance of tonic contractions and is suppressed prior to and during voluntary movement [1], [2], [3], [4], [5], [6] and [7]. This and other correlative evidence suggests that beta activity might promote tonic contraction, while impairing motor processing related to new movements [3], [8] and [9]. Hence, bursts of beta activity in the cortex are associated with a strengthening of the motor effects of sensory feedback during tonic contraction and with reductions in the velocity of voluntary movements [9], [10] and [11]. Moreover, beta activity is increased when movement has to be resisted or voluntarily suppressed [7], [12] and [13]. Here we use imperceptible transcranial alternating-current stimulation to entrain cortical activity at 20 Hz in healthy subjects and show that this slows voluntary movement. The present findings are the first direct evidence of causality between any physiological oscillatory brain activity and concurrent motor behavior in the healthy human and help explain how the exaggerated beta activity found in Parkinson's disease can lead to motor slowing in this illness [14].


Journal reference
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRT-4XBX6J1-4&_user=777686&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000043031&_version=1&_urlVersion=0&_userid=777686&md5=6054b92cd8615afcad3e4ab16ee71941

New Drug promises to stop the Flu

Fiercebiotech.com reports that the drug peramivir (Vaccination) has recently been approved for phase 3 clinical trials as an antiviral.It is being developed by Birmingham (UK) based biocyst.Although the drug was previously developed by johnson and johnson for oral use, it showed little or no effect via this route. Biocyst is developing an inject able vaccine that is much more effective at attacking the virus.The clinical trials are said to be finished by 2011 so the vaccine could be available in the next 5 years...Governments around the world are already stock piling the drug in the event of other swine flu type outbreaks......

For details on the specific science of peramivir wikipedia has a good summary.Again always consult a professional on these matters.......

References
http://www.fiercevaccines.com/story/biocryst-outlines-phase-iii-plans-peramivir/2009-10-01
http://en.wikipedia.org/wiki/Peramivir

New therapy for heart failure

In the article entitled Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events.The new england journal of medicince outlines clinical trial studies that show that cardiac-ressynchronization combined with an implantable cardioverter–defibrillator (ICD)reduced heart failure events.

Article preview

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure EventsArthur J. Moss, M.D., W. Jackson Hall, Ph.D., David S. Cannom, M.D., Helmut Klein, M.D., Mary W. Brown, M.S., James P. Daubert, M.D., N.A. Mark Estes, III, M.D., Elyse Foster, M.D., Henry Greenberg, M.D., Steven L. Higgins, M.D., Marc A. Pfeffer, M.D., Ph.D., Scott D. Solomon, M.D., David Wilber, M.D., Wojciech Zareba, M.D., Ph.D., for the MADIT-CRT Trial Investigators.

Background

This trial was designed to determine whether cardiac-resynchronization therapy (CRT) with biventricular pacing would reduce the risk of death or heart-failure events in patients with mild cardiac symptoms, a reduced ejection fraction, and a wide QRS complex.

Methods

During a 4.5-year period, we enrolled and followed 1820 patients with ischemic or nonischemic cardiomyopathy, an ejection fraction of 30% or less, a QRS duration of 130 msec or more, and New York Heart Association class I or II symptoms. Patients were randomly assigned in a 3:2 ratio to receive CRT plus an implantable cardioverter–defibrillator (ICD) (1089 patients) or an ICD alone (731 patients). The primary end point was death from any cause or a nonfatal heart-failure event (whichever came first). Heart-failure events were diagnosed by physicians who were aware of the treatment assignments, but they were adjudicated by a committee that was unaware of assignments....

References
http://content.nejm.org/cgi/content/short/361/14/1329

New Drug to Treat Major Depression

Glaxosmith kline is conducting or will have conducted clinical trial studies of compound GW856553 to treat major depression.The study is in phase 2 clinical trials which means it should take another 5 years pending approval, before it hits the pharmacy shelves.Its truly promising to see active research going into treating depression.It is a disease often underdiagnosed and payed little attention too.Its about time to move on from fluoxetine(prozac) which has a host of side effects....
Check out the reference below if you are interested, they are currently recruiting research candidates to take part in the clinical trials.........

Stay well all....

Reference
http://clinicaltrials.gov/ct2/show/NCT00976560?term=NEW+DRUGS&rank=20

FDA approves new ADHD treatment

Acording to the FDA website the drug INTUNIV(guanfacin) has resently been approved for use in the treatment of ADHD in children and adolescents aged 6 to 17.According to the drugs official website the clinical trials for this drug where shown to relieve symtoms of ADHD.The drug is expected to be in pharmacies accross the USA by november 2009.

This is encouraging news, ADHD can be very desruptive to peoples lives

References
http://www.intuniv.com

New radiotherapy treatment for lung cancer

The lancet outlines some new treatment advances for those with non-operable small cell lung cancer (SCLC).They is a by SUNY department of radiation on the use of different radiation based treatment regimes to treat SCLC. In the article it mentions four major radiation based treatment types for SCLC. These include:

1)External beam radiotherapy
2)Three-dimensional conformal radiotherapy
3)Stereotactic body radiation therapy (SBRT)
4)Intraoperative brachytherapy
5)Radiofrequency ablation

For details of the the research check reference and as always ask docter or suitable medical professional regarding these new treatments...takecare and stay well

Reference
The Lancet Oncology, Volume 10, Issue 9, Pages 885 - 894, September 2009

Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials
Original TextJohn W Powell MD a, Elisabeth Dexter MD b, Ernest M Scalzetti MD c, Prof Jeffrey A Bogart MD a

Rheumatoid Arthritis fairly new drugs

This is a review or recap of drugs(some on the market) used to treat arthritis.The article in the new endland medical journal gives a summary of the main drugs avaliable and runs through their mode of action (how they work to make you feel better).They is also of these newish drugs includes Leflunomide,Etanercept,Infliximab
Adalimumab.

I realise that some people will have heard of these treatments but this site is also about introducing new fairly recent treatment options to those who perhaps dont know.As always ask your docter or pharmacist about any questions regarding these drugs.

Extract

New Drugs for Rheumatoid Arthritis

Nancy J. Olsen, M.D., and C. Michael Stein, M.B., Ch.B.

Rheumatoid arthritis affects approximately 1 percent of the U.S. population and can cause irreversible joint deformities and functional impairment. The cause of this autoimmune disease remains obscure, but greater understanding of the underlying mechanisms has facilitated the development of new drugs and revolutionized treatment.1

Specific CD4+ T cells are involved in the induction of the immune response in rheumatoid arthritis, most likely as a response to an unknown exogenous or endogenous antigen. Consequently, recruited monocytes, macrophages, and fibroblasts produce cytokines such as tumor necrosis factor (TNF-) and interleukin-1 within the synovial cavity. These cytokines are central to a damag


Reference
New england medical journal Volume 350:2167-2179 May 20, 2004 Number 21

New treatment for children with eye cancer

The times has an interesting article highlighting treatment procedures for children with eye cancer.The procedure allows docters to specifically target the chemotherapy drugs for cancer cells and save the normal tissue.What this means is that they is a high chance that the patient can recover with his or her eye sight intact.


Reference
http://www.timesonline.co.uk/tol/life_and_style/health/article6799343.ece

Asprin as therapy for colorectal cancer

This is an extract of a paper which states new findings about asprins use in treating
colorectal cancer the full story is in JAMA. 2009;302(6):688-689

Extract

Even before the time of Hippocrates, willow extracts, which contain salicylates, were used in medicine as analgesic, anti-inflammatory, and antipyretic agents. Acetylsalicylic acid was isolated in the mid-19th century, and since 1899 when it was patented, aspirin has enjoyed global popularity. The relatively recent discovery of its antiplatelet activity has also led to the widespread use of aspirin as an antistroke and cardioprotective agent, but the list of its medical applications continues to increase.

More than 30 years ago, Sporn et al2 coined the term chemoprevention to describe and propose the use of oral drugs, chemicals, or supplements to reduce the risk of cancer. In the ensuing decades, chemoprevention research has generated high hopes and enormous increases in funding, although only a few agents have shown efficacy in clinical trials, and of those few, most are too toxic for use by average-risk individuals. In addition...... .

Can Killing a hedgehog kill cancer?

Yes,the latest issue of the new england medical journal highlights a new drug GDC-0449 in clinical trials which blocks the so called hedgehog signiling pathway which is activated during a wide range of cancers.It is belived that blocking this pathway could yield a greater degree of selectivity and as a result produce less sideeffects.
For details on the study buy the lastest issue of the new england medical journal.

Its always good that to see new treatments that take into account sideeffects.....

Reference
new england medical journal, septemter 17 2009

Type 2 diabetes treatments (information)

WebMD has a pretty comprehnsive list on drugs that are in current and possibly future use for type 2 diabetes patients, the article is quite insightful.One thing is it looks at combination therapy to treat patients.e.g Metformin and Precose.It also talks about Januvia (sitagliptin).

Refer to http://diabetes.webmd.com/features/new-type-2-diabetes-treatment-options?page=2

New Treatment for respiratory failure

With swine flu season approaching, they is an intresting article at lancet that covers a new treatment for acute respiratory failure .The treatment is called edextracorporeal membrane oxygenation (ECMO) which works by bypassing the heart and lungs to treat acute respiratory failure.Details of the trial can be found here: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61069-2/fulltext

Takecare everyone

new treatment for asthma

A new device called the alair system is pending approval by the FDA to treat asthma patients chronic and acute.The device uses radiowaves or radiofrequency energy to improve the quality of patients lives.If approved this would be the first non-pharmaceutical intervention treatment for asthma.For details on the study visit the reference link below it goes into detail about the trials conducted,which involved some 297 asthmatics using this treatment.

Reference
http://esciencenews.com/articles/2009/05/18/new.severe.asthma.treatment.uses.radiofrequency.energy.improve.patient.quality.life

New drug for high blood pressure

A new drug darusentan is in clinical trails for patients with treatment resistant hypertention.The reasearch is funded by pharmacuetical company gliead.

For full details go to
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61500-2/fulltext

Advanced breast cancer treatment

In its pipeline of drugs, the pharmaceutical company astrazeneca has the drug faslodex in phase 3 clinical trials for the treatment of firstline advanced breast cancer.The company records show that it is due to get a marketing authorisation for this drug Q4 2009 which is this winter.

Faslodex facts
This is what is classified as an ostrogen receptor antagonist and has shown very promising results its due for a 2010 release.......ask your GP or go to
http://www.faslodex.net/

Treatment for crohns (cimizia)

This might be abit of old news but webmd has an article talking about the drug cimizia for the treatment of CD......its good to hear that research in this field is paying off.For details visit the site below.

Visit:http://www.webmd.com/ibd-crohns-disease/crohns-disease/news/20080423/fda-oks-new-crohns-disease-drug-cimzia

Omapro to treat chronic myeloid leukemia

Story coverved by the hearld sun australia talks about new drug that has been submited to the FDA for approval in the treatment on myeloid leukemia.Whats amazing about this story is that it only took them about 5 years to develope the drug..this means that drugs to help suffers of this condition can comeout twice as fast and thats a good thing.

reference
http://www.heraldsun.com.au/business/geelong-biotech-chemgenex-in-cancer-drug-first/story-e6frfh4f-1225771414522

prozac could kill cancer cells

Reaserch published this years indicates that those taking antipsychotic drugs such are prozac are less prone to cancer.The results have shown that these drugs reduce the probability of the cancer to survive.Further research has also shown that using cholesterol lowering treatments such as statins can further limit the growth of a prospective cancer.

Reference

http://www.medicalnewstoday.com/articles/160600.php

New treatment for (SCLC),prostate,colorectal cancer

The pharmaceutical company poniard has developed the drug picoplatine for the treatment of small cell lung cancer (SCLC).The drug is in phase 3 clinical trials and data from its Phase III SPEAR trial is to be announced soon.This is a very promising step, a drug that reaches phase will see its self on the shelf in 2 to 3 years pending any further verification by regulatory agencies like the FDA or MHRA.
The drug has also been in phase 2 clinical trials for treatment in colorectal and prostate cancer and the results look promising...(Watch this space is all i have to say)

Reference
http://www.fiercebiotech.com/special-reports/five-biotech-companies-watch

Clinical trial news (Ovarian cancer)

It looks promising for overian cancer suffers it appears that glaxo has a drug in phase 1 clinical trials its a biopharmaceutical called iboctadekin† + Doxil its a IL18 immunomodulator + topoisomerase ll inhibitor and has been indicated for ovarian cancer.As it is still in phase 1 in clinical trials it has a long way to go, about 7 years or so.....

Clinical trial news (COPD)

It appears glaxo is working on a drug that can treat COPD and depression in the company documents the drug is Iosmapimod (856553) a p38 kinase inhibitor which is indicated for cardiovascular disease (also COPD & depression).This is promising news for those friends and families afflicted by the diesease....The drug is said to be in phase 2 clinical trials which means there is atleast another 4 year or so until it is on the pharmacy shelf.

What killed micheal jackson

Propofol has been in the news recently, it has been speculated to have been the cause for micheal jacksons death but what is it exactly......
Propofol is a short-acting intravenous anesthetic agent usually used in a clinical setting for operations to sedate the patient....Quiet what the good docter was doing giving MJ the medicine we will never know but i think it might have been a assited succide or a malpractise on the docters part....

WEEKLY CLINICAL TRAIL NEWS

Chronic Lymphocytic Leukemia

It has been resently reported that Rituximab Improves outcomes for Patients With Chronic Lymphocytic Leukemia.This basically means in addition to regular chemotherapy patients will be have this drug to help them beat the cancer.This fiding follows clinical trials of some 817 patients.Furthe deals can bee found in an article from the NCI Cancer Bulletin, vol. 5/no. 25, Dec. 16, 2008 or go to
http://www.cancer.gov for details on the trial.

NEW CANCER TREATMENTS

Wired science looks at the possible new therapies for cancer which include;

Epigenetic Drugs
Vaccines
Small Molecules
Viruses
Gene Knockdown

This is an interesting article, especially epigenetic drugs seem to sho the most promise.check out the full article at http://www.wired.com/wiredscience/2008/04/top-5-viable-ca/

Post a comment here and let us know what you think about the article

SWINE FLU AVALIABLE TREATMENTS

Is treatment available and does it work?

Testing has shown that the human swine influenza H1N1 can be treated with the antivirals oseltamavir (Tamiflu) and zanamivir (Relenza), according to the UK's Health Protection Agency. The health secretary, Alan Johnson, said yesterday that Tamiflu had proved effective on patients in Mexico. Demand has historically been greatest for Tamiflu, which comes in tablet form, while Relenza must be inhaled.


see the rest of this article at http://www.guardian.co.uk/world/2009/apr/27/swine-flu-treatment-antivirals

Check out the following link if you want to know more about Temazepam

http://www.youtube.com/watch?v=x-7_qM2LdtU&feature=channel_page

Insomnia

Which drugs are used for Insomnia ?

Mainly two classes...

Benzodiazepines hypnotics & Non-Benzodiazepine hypnotics

1. Benzodiazepines hypnotics
Nitrazepam , Flurazepam, Loprazolam, Lormetazepam, Temazepam....

2. Non-Benzodiazepine hypnotics

Zaleplon, Zolpidem Tartrate, Zopiclone...

Also, Could be Chloral and derivatives....

which it seems like their role as hypnotics is now very limited.

Antihistamine is used as well...

I want you guys to comment those following drugs....
Any experience... or any personal opinion...

Do Diet Pills Really Work?

The answer is yes. Metformin can help you lose weight. But there's some scary (and, um, unsavory) info in the fine print.Check out this intresting article from

http://www.redbookmag.com/health-wellness/advice/diet-pills-yl

which tells you what you must know about the new weight-loss drugs.